Vimarsana
Biggest News Aggregation in the World

Disease Week News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Disease Week. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Disease Week Today - Breaking & Trending Today

Weight loss drugs up abdominal paralysis risk: Study | India News - Vimarsana News

Weight loss drugs up abdominal paralysis risk: Study | India News

India News: A new US study suggests that weight-loss medications like Wegovy and Ozempic may have rare but serious side effects, including abdominal paralysis, li

Biodexa Pharmaceuticals PLC Announces Positive Statistically Significant Phase 2 Clinical Trial Results of eRapa? in Familial Adenomatous Polyposis Scheduled for Presentation at the 2024 Digestive Disease Week Annual Meeting - Vimarsana News

Biodexa Pharmaceuticals PLC Announces Positive Statistically Significant Phase 2 Clinical Trial Results of eRapa? in Familial Adenomatous Polyposis Scheduled for Presentation at the 2024 Digestive Disease Week Annual Meeting

Biodexa Pharmaceuticals PLC announced that results of a Phase 2 clinical trial of eRapa in Familial Adenomatous Polyposis are scheduled for presentation at the prestigious 2024 Digestive Disease...

Guselkumab Continues Winning Streak in Crohn's Disease - Vimarsana News

Guselkumab Continues Winning Streak in Crohn's Disease

Dual-acting IL-23 inhibitor tops placebo, ustekinumab in phase III trials

New Peer-Reviewed Clinical Studies Show SonarMD Reduces Emergency Department Visits and Hospitalizations for Patients with Ulcerative Colitis and Crohn's Disease - Vimarsana News

New Peer-Reviewed Clinical Studies Show SonarMD Reduces Emergency Department Visits and Hospitalizations for Patients with Ulcerative Colitis and Crohn's Disease

/PRNewswire/ -- SonarMD today presented positive results from two large, longitudinal studies evaluating several major drivers of medical costs in people...

Endoscopic Ablation Reduces 'Hunger Hormone,' Yields Weight Loss in Early Trial - Vimarsana News

Endoscopic Ablation Reduces 'Hunger Hormone,' Yields Weight Loss in Early Trial

First-in-human study targets ghrelin production with mucosal ablation as obesity treatment